98 related articles for article (PubMed ID: 23202297)
1. Comparison between PUN and Tofts models in the quantification of dynamic contrast-enhanced MR imaging.
Mazzetti S; Gliozzi AS; Bracco C; Russo F; Regge D; Stasi M
Phys Med Biol; 2012 Dec; 57(24):8443-53. PubMed ID: 23202297
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided diagnosis of prostate cancer using multi-parametric MRI: comparison between PUN and Tofts models.
Mazzetti S; Giannini V; Russo F; Regge D
Phys Med Biol; 2018 May; 63(9):095004. PubMed ID: 29570456
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm.
Bergamino M; Barletta L; Castellan L; Mancardi G; Roccatagliata L
J Digit Imaging; 2015 Dec; 28(6):748-54. PubMed ID: 25776769
[TBL] [Abstract][Full Text] [Related]
4. Phenomenological universalities: a novel tool for the analysis of dynamic contrast enhancement in magnetic resonance imaging.
Gliozzi AS; Mazzetti S; Delsanto PP; Regge D; Stasi M
Phys Med Biol; 2011 Feb; 56(3):573-86. PubMed ID: 21212471
[TBL] [Abstract][Full Text] [Related]
5. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
8. Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer.
Korporaal JG; van Vulpen M; van den Berg CA; van der Heide UA
Invest Radiol; 2012 Jan; 47(1):41-8. PubMed ID: 21610505
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
Isebaert S; De Keyzer F; Haustermans K; Lerut E; Roskams T; Roebben I; Van Poppel H; Joniau S; Oyen R
Eur J Radiol; 2012 Mar; 81(3):e217-22. PubMed ID: 21349667
[TBL] [Abstract][Full Text] [Related]
10. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach.
Cheng HL
J Magn Reson Imaging; 2009 Oct; 30(4):864-72. PubMed ID: 19787732
[TBL] [Abstract][Full Text] [Related]
11. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
13. The effect of temporal sampling on quantitative pharmacokinetic and three-time-point analysis of breast DCE-MRI.
Fluckiger JU; Schabel MC; Dibella EV
Magn Reson Imaging; 2012 Sep; 30(7):934-43. PubMed ID: 22513074
[TBL] [Abstract][Full Text] [Related]
14. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
18. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
19. Spectral clustering applied for dynamic contrast-enhanced MR analysis of time-intensity curves.
Tartare G; Hamad D; Azahaf M; Puech P; Betrouni N
Comput Med Imaging Graph; 2014 Dec; 38(8):702-13. PubMed ID: 25179917
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.
Bonekamp D; Macura KJ
Top Magn Reson Imaging; 2008 Dec; 19(6):273-84. PubMed ID: 19512849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
